Jeffrey G Spragens
CIK 1410620 · President and CEO · last filed 2024-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.0K
Companies
2
Total Filings
22
Lifetime Open-Market Net
$130.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SABSW | Director | 394,989 | $0.01 | $5.0K | $0 | 4 | 2024-07-17 |
| SAB Biotherapeutics, Inc. (BCYPW) Delisted | Director | 13,000 | $1.10 | $14.3K | $130.9K | 1 | 2021-10-05 |
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-04-15 | — | Buy (P) | +12,500 | $14.6K | |
| 2011-03-11 | — | Grant (A) | — | $0 | |
| 2010-10-05 | — | Buy (P) | +2,000 | $4.0K | |
| 2010-09-24 | — | Buy (P) | +2,000 | $4.1K | |
| 2010-09-13 | — | Mixed | +123,680 | $106.6K | |
| 2010-02-18 | — | Grant (A) | — | $0 | |
| 2010-01-14 | — | Buy (P) | — | $0 | |
| 2009-02-12 | — | Grant (A) | — | $0 | |
| 2008-05-29 | — | Buy (P) | +46,511 | $100.0K | |
| 2008-03-20 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.